Abstracts of the 7th International Conference on Lactoferrin / Résumés de la 7e Conférence internationale sur la lactoferrine

s of the 7th International Conference on Lactoferrin / Résumés de la 7e Conférence internationale sur la lactoferrine N. Kumagai, S. Tsunematsu, H. Hamano, K. Yamauchi, and K. Tsuchimoto 385 Oral administration of lactoferrin enhances viral decline in patients with genotype-1B-related chronic hepatitis C treated with Peginterferon a-2B plus ribavirin T. Kuhara, K. Yamauchi, and M. Takase 385 Oral administration of lactoferrin raises NK cell activity in mice Zigang Tian, Jianhua Wang, Da Teng, Yalin Yang, Fan Zhang, Xingjun Feng, Lingyun Wei, Ying Fan, and Jin Luo 386 Comparison of antimicrobial activity between lactoferricin B 15 derivative and antibiotics N.A. Thomson, A. Chand, and C.J. Fee 386 Batch extraction of lactoferrin from raw whole milk R. Sato, Y. Kobayashi, S. Kobayashi, J. Sato, Y. Yamada, Y. Naito, and J. Sasaki 387 Modulatory effects of oral administration of entericcoated lactoferrin on neutrophil functions in Feline Immunodifiency Virus (FIV) infected cats J.G.M. Bolscher, M.I.A. Van der Kraan, K. Nazmi, H. Kalay, C. Grun, W. Van‘t Hof, E.C.I. Veerman, and A.V. Nieuw Amerongen 387 Novel antimicrobial lfampin from lactoferrin released by a one-enzyme strategy M. Kaito, K. Yamauchi, M. Iwasa, Y. Kobayashi, N. Fujita, H. Tanaka, S. Horike, M. Konishi, S. Watanabe, S. Teraguchi, and Y. Adachi 388 Efficacy of oral bovine lactoferrin on the interferon a plus ribavirin therapy for chronic hepatitis C patients with genotype 1b and a high viral load K. Mitsukawa, K. Otsuki, M. Sawada, K. Yakuwa, A. Hasegawa, Y. Sasaki, H. Chiba, M. Nagatsuka, and T. Okai 388 Cervical inflammatory cytokines and other markers in cervical mucus of pregnant women with bacterial vaginosis A.M. Degener, G. Longhi V, M. Mischitelli, C. Longhi, M.P. Conte, P. Valenti, L. Seganti, M. Marchetti, and F. Superti 389 Lactoferrin inhibits human BK polyomavirus adsorption to Vero cells H.E. Indyk and E.L. Filonzi 389 Determination of lactoferrin in bovine milk, colostrum and infant formulas by optical biosenso analysis Zigang Tian, Jianhua Wang, Da Teng, Yalin Yang, Fan Zhang, Xingjun Feng, Lingyun Wei, Ying Fan, and Jin Luo 390 Design and construction of tandem multimers lactoferricin B15 derivative for high-level expression in Escherichia coli Rahman Md. Morshedur, Woan-Sub Kim, Toshiaki Ito, Haruto Kumura, and Keiichi Shimazaki 390 Visualization of lactoferrin binding to bifidobacteria H. Wakabayashi, T. Andoh, K. Yamauchi, and M. Takase 391 Antimicrobial activity of lactoferrin against Enterobacter Sakazakii Motoh Iwasa, Masahiko Kaito, Koji Yamauchi, Ryosuke Sugimoto, Mika Yamamoto, Naoki Nakagawa, Masayoshi Konishi, Shozo Watanabe, Susumu Teraguchi, and Yukihiko Adachi 391 Lactoferrin inhibits lipid peroxidation in chronic hepatitis C patients K. Nakashima, Y. Yumoto, and Y. Furuichi 392 Effects of human lactoferrin on the chemotactic response of THP-1 cells S. Tomita, T. Uotani, N. Sueki, K. Fujimoto, J. Matsuyama, and Y. Benno 392 Promotional effect of bovine lactoferrin on the growth of bifidobacteria and their mechanism S.-A. Turner and N.A. Thomson 393 Lactoferrin in bovine milk is not affected by strain of cow or level of feed S. Kobayashi, R. Sato, O. Inanami, T. Yamamori, M. Kuwabara, Y. Naito, and M. Takase 393 Bovine lactoferrin reduces concanavalin A-induced interferon-g expression of peripheral blood mononuclear cells in FIV-negative and FIV-positive cats K. Otsuki, K. Yakuwa, M. Sawada, K. Ichizuka, M. Nagatsuka, T. Kimura, and T. Okai 394 Effect of enteric-coated lactoferrin on constipation during pregnancy S. Farnaud, Z. Wang, R. Dybowski, E.W. Odell, and R.W. Evans 394 Towards a tree-induction approach to antimicrobial activity analysis of cationic peptides Y. Yumoto, K. Nakashima, and Y. Furuichi 395 Distribution of human lactoferrin in periodontal pockets Jeremy H. Brock, Madalina Icriverzi, Mihaela Trif, Flori Chelu, Gabriela Negroiu, and Anca Roseanu 395 Effect of lactoferrin on murine melanoma B16-F1 cells; possible mode of action K. Kai, M. Itagaki, M. Uematsu, Y. Miyazaki, D. Fukumoto, I. Iwaski, H. Tsuchida, Y. Taguchi, S. Ishiguro, K. Kumagai, T. Yanaka, and M. Mochizuki 396 Efficacy and safety of lactoferrin as a new preventive reagent for bovine mastitis E.R. Sadchikova, I.L. Goldman, A.N. Krasnov, S.G. Kadulin, S.G. Georgieva, T.G. Ermolkevich, Ya. G. Gursky, N.V. Gnuchev, and G.P. Georgiev 396 Human lactoferrin in milk of transgenic animals Yokoyama Saichiro, Koshio Shunsuke, Teshima Shin-ichi, Ishikawa Manabu, ReyesCatacutan Mae, Takakura Natsuko, and Oshida Kyoichi 397 Effect of dietary bovine lactoferrin on tolerance to air exposure stress and response in branchial heatshock protein under low-salinity conditions in grouper Epinephelus coioides K. Kai, Y. Komine, K. Komine, M. Ohta, and K. Kumagai 398 Therapeutic effects of bovine lactoferrin on staphylococcal mastitis during non-lactating period E.F. Haney, F. Lau, and H.J. Vogel 398 NMR structural studies of bovine and human lactoferrampin, novel antimicrobial peptides from lactoferrin K. Higami, K. Ishii, M.L. Shinohara, T. Ikehara, H. Nagai, M. Watanabe, Y. Sumino, K. Miki, and K. Yamauchi 399 Long-term follow-up of chronic hepatitis C patients administered oral lactoferrin M.S. Nam, M.C. Cho, H.C. Bae, and D.Y. Yoon 399 Effects of lactoferrin on adipogenesis in 3t3-l1 cells and obesity mice Tamaki Yukimichi and Ando Kunio 400 Lactoferrin in dentistry Shaper Mirza, William H. Benjamin Jr., and David E. Briles 400 Killing of pneumococci by apolactoferrin is dependent on cleavage of apolactoferrin by the pneumococcal surface serine protease PrtA Shaper Mirza and David E. Briles 401 Cleavage of human lactoferrin by a surfaceassociated serine protease (PrtA) of Streptococcus pneumoniae David E. Briles and Shaper Mirza 401 PspA inhibits the antibacterial effect of lactoferrin on Streptococcus pneumoniae Jianhua Wang, X. Feng, A. Shan, D. Teng, Y. Yao, Y. Shao, S. Liu, and F. Zhang 402 Fusion expression of bovine lactoferricin in Escherichia Coli K. Ishii, Y. Sumino, M. Kogame, K. Higami, M.I. Shinohara, K. Matsumaru, M.A. Shinohara, H. Nagai, M. Watanabe, K. Miki, K. Yamauchi, and S. Teraguchi 402 The efficacy of bovine lactoferrin and ifn-a 2b combination therapy following 24-week regimen of ribavirin plus ifn-a 2b for chronic hepatits C patients infected with genotype 1b and high viral load